Recent Advances of Endothelial Progenitor Cells in Vascular Endothelial Function and Tissue Repair

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Cardiovascular System".

Deadline for manuscript submissions: 15 July 2024 | Viewed by 1547

Special Issue Editors


E-Mail Website
Guest Editor
1. Clinical Ergospirometry, Exercise and Rehabilitation Laboratory, National and Kapodistrian University of Athens, 106 75 Athens, Greece
2. Cardiac Surgery ICU, Onassis Cardiac Surgery Center, 176 74 Athens, Greece
Interests: critical care medicine; CPET applications; cardiopulmonary rehabilitation; rehabilitation in critical ill patients; microcirculation; exercise training; near-infrared spectroscopy; lung sonography; CHF; pulmonary arterial hypertension; left ventricle assist device; ECMO

E-Mail
Guest Editor
1. Clinical Ergospirometry, Exercise and Rehabilitation Laboratory, National and Kapodistrian University of Athens, 106 75 Athens, Greece
2. Department of Cardiology, 417 Army Share Fund Hospital of Athens (NIMTS), 115 21 Athens, Greece
Interests: heart failure; endothelial progenitor cells; endothelium; myocardial infarction; revascularization; cardiopulmonary resuscitation; myocarditis; cardiopulmonary exercise testing; exercise training; rehabilitation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue entitled “Recent Advances of Endothelial Progenitor Cells in Vascular Endothelial Function and Tissue Repair” focuses on the most updated knowledge in the field of Endothelial Progenitor Cells and, most specifically, on the:

  1. Review of the existing methods or new proposals for identification and quantification;
  2. Potential pathophysiological mechanisms of mobilization, differentiation, vascular protection and tissue repair in a wide spectrum of diseases and clinical syndromes;
  3. Clinical translation of the existing findings of original research;
  4. Future perspectives and potential clinical indications of Endothelial Progenitor Cells.

We are pleased to invite authors to submit their original research, recommendation articles, and/or reviews covering all aspects of Endothelial Progenitor Cells. Participation in this Special Issue through the submission of a manuscript could be an excellent opportunity for senior researchers to enrich their CVs, for doctoral or post-doctoral trainees to gain experience in writing reviews and for institutions to present their original research in a high-quality journal.

Dr. Stavros Dimopoulos
Dr. Christos Kourek
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at mdpi.longhoe.net by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • endothelial progenitor cells
  • endothelium
  • vascular endothelial function
  • tissue repair
  • regeneration
  • vascular homeostasis
  • infusion
  • mobilization
  • differentiation
  • translational research

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

16 pages, 860 KiB  
Review
Cellular and Noncellular Approaches for Repairing the Damaged Blood–CNS–Barrier in Amyotrophic Lateral Sclerosis
by Larai Manora, Cesario V. Borlongan and Svitlana Garbuzova-Davis
Cells 2024, 13(5), 435; https://doi.org/10.3390/cells13050435 - 29 Feb 2024
Viewed by 1264
Abstract
Numerous reports have demonstrated the breakdown of the blood–CNS barrier (B-CNS-B) in amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease. Re-establishing barrier integrity in the CNS is critical to prevent further motor neuron degeneration from harmful components in systemic circulation. Potential therapeutic strategies [...] Read more.
Numerous reports have demonstrated the breakdown of the blood–CNS barrier (B-CNS-B) in amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease. Re-establishing barrier integrity in the CNS is critical to prevent further motor neuron degeneration from harmful components in systemic circulation. Potential therapeutic strategies for repairing the B-CNS-B may be achieved by the replacement of damaged endothelial cells (ECs) via stem cell administration or enhancement of endogenous EC survival through the delivery of bioactive particles secreted by stem cells. These cellular and noncellular approaches are thoroughly discussed in the present review. Specific attention is given to certain stem cell types for EC replacement. Also, various nanoparticles secreted by stem cells as well as other biomolecules are elucidated as promising agents for endogenous EC repair. Although the noted in vitro and in vivo studies show the feasibility of the proposed therapeutic approaches to the repair of the B-CNS-B in ALS, further investigation is needed prior to clinical transition. Full article
Show Figures

Figure 1

Back to TopTop